Raymond James began coverage on shares of Guardian Pharmacy Services (NYSE:GRDN - Free Report) in a research note published on Monday morning, MarketBeat.com reports. The firm issued an outperform rating and a $21.00 price objective on the stock.
Separately, Truist Financial started coverage on Guardian Pharmacy Services in a research note on Monday. They issued a "buy" rating and a $22.00 price objective on the stock.
Read Our Latest Research Report on Guardian Pharmacy Services
Guardian Pharmacy Services Trading Up 1.9 %
Shares of NYSE GRDN traded up $0.34 during mid-day trading on Monday, hitting $18.02. The company had a trading volume of 119,436 shares, compared to its average volume of 173,296. Guardian Pharmacy Services has a 1-year low of $14.16 and a 1-year high of $20.10.
Insider Buying and Selling at Guardian Pharmacy Services
In other Guardian Pharmacy Services news, Director Thomas J. Salentine, Jr. purchased 35,714 shares of the business's stock in a transaction on Friday, September 27th. The shares were bought at an average cost of $14.00 per share, for a total transaction of $499,996.00. Following the completion of the purchase, the director now directly owns 35,714 shares in the company, valued at approximately $499,996. The acquisition was disclosed in a legal filing with the SEC, which can be accessed through this link.
Institutional Trading of Guardian Pharmacy Services
A hedge fund recently bought a new stake in Guardian Pharmacy Services stock. Allspring Global Investments Holdings LLC acquired a new position in shares of Guardian Pharmacy Services, Inc. (NYSE:GRDN - Free Report) during the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm acquired 325,000 shares of the company's stock, valued at approximately $5,460,000. Allspring Global Investments Holdings LLC owned about 0.52% of Guardian Pharmacy Services as of its most recent filing with the Securities & Exchange Commission.
About Guardian Pharmacy Services
(
Get Free Report)
Guardian Pharmacy Services, Inc, a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes.
Featured Articles
Before you consider Guardian Pharmacy Services, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Guardian Pharmacy Services wasn't on the list.
While Guardian Pharmacy Services currently has a "hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
